Allegiant Health
United States 80 employees Updated 9 July 2026
Allegiant Health is a finished-dose manufacturer based in United States. It appears in 20 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 11 April 2025 as NAI.
1
registered plants
1 with an FDA FEI number
20
filings
across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 11 April 2025 NAI US FDA
- 13 June 2019 NAI US FDA
- 2 November 2016 VAI US FDA
- 2 June 2015 VAI US FDA
- 7 May 2014 VAI US FDA
- 16 May 2013 VAI US FDA
- 15 November 2011 VAI US FDA
- 13 May 2011 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Deer Park, United States | 3001195380 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| US FDA | 20 | 1 |
Comparing suppliers?
Choose your molecules and target markets. Allegiant Health comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was NAI, on 11 April 2025.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates